| Not Yet Recruiting | Collaborative Risk-stratified Investigation in Teen Inpatients With Critical Illness: Anticoagulation With LMW NCT06628778 | Johns Hopkins All Children's Hospital | Phase 3 |
| Not Yet Recruiting | Delivery and Implementation of a Randomised Crossover Trial on Thrombosis NCT06937372 | Queen Mary University of London | N/A |
| Not Yet Recruiting | Design and Rationale of the COLT Study NCT07432529 | Azienda Sanitaria Locale ASL 6, Livorno | Phase 3 |
| Not Yet Recruiting | Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hemato NCT07493304 | Regeneron Pharmaceuticals | Phase 3 |
| Not Yet Recruiting | Duke Virtual IntEgrated Workflow NCT07406074 | Duke University | — |
| Recruiting | Early Exercise-Based Rehabilitation in Patients Hospitalized for Acute Pulmonary Embolism NCT07143539 | Insel Gruppe AG, University Hospital Bern | N/A |
| Recruiting | External Validation of the CLOVER Score for Detecting Occult Cancer in Venous Thromboembolism Patients NCT07310693 | Infanta Leonor University Hospital | — |
| Not Yet Recruiting | Hip Fracture Surgery Arterial and Venous Thrombotic Events Prevention NCT07228663 | McMaster University | Phase 3 |
| Not Yet Recruiting | Informative Video Before LMWH Postpartum - Randomized Controlled Trial NCT07168005 | Wolfson Medical Center | N/A |
| Recruiting | Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum Thrombosis NCT07140211 | Marc Blondon | Phase 3 |
| Recruiting | REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults NCT07015905 | Regeneron Pharmaceuticals | Phase 3 |
| Recruiting | Pulsed Electromagnetic Field Therapy or Pneumatic Compression VTE Prophylaxis NCT06958588 | Science Valley Research Institute | Phase 4 |
| Recruiting | Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk NCT06845423 | University Hospital, Brest | Phase 4 |
| Not Yet Recruiting | Achilles Tendon Rupture - Intervention With Electrical Stimulation NCT06601088 | Karolinska University Hospital | N/A |
| Not Yet Recruiting | Anti-Xa Guided Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism Following Traum NCT06662253 | Alexandre Tran | Phase 2 / Phase 3 |
| Recruiting | Heat Shock Protein 47 in Thrombosis NCT06731673 | University of Aarhus | — |
| Recruiting | Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery NCT07439991 | The First Hospital of Jilin University | — |
| Completed | Dimolegin® (60 mg) Given Once Daily in Patients Undergoing Total Hip or Knee Replacement Compared to Enoxapari NCT07124819 | Avexima Diol LLC | Phase 3 |
| Unknown | Molecular Imaging of Active Venous Thrombus With Positron Emission Tomography (PET) NCT06057844 | University Hospital, Brest | N/A |
| Recruiting | Effects of Genomic Profiles on Thromboembolic Risk in Patients With Locally Advanced or Metastatic Non-small-c NCT07288632 | University Of Perugia | — |
| Completed | The Safety and Effectiveness of Warfarin Vs Apixaban in Patients With NVAF/ VTE and ESKD on Dialysis NCT06606275 | Abu Dhabi Health Services Company | — |
| Active Not Recruiting | Xueshuantong Injection (Lyophilized) in the Prevention of Venous Thromboembolism (VTE) in Hospitalized Patient NCT06443905 | China-Japan Friendship Hospital | — |
| Completed | Efficacy of Aspirin in Preventing Venous Thromboembolism NCT06635317 | Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado | Phase 4 |
| Completed | Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patient NCT04243122 | Ottawa Hospital Research Institute | Phase 2 |
| Unknown | Diagnostic and Prognostic Prediction Models for Chinese Patients With Venous Thromboembolism NCT03802929 | Ya-Wei Xu | — |
| Completed | Study to Gather Information How Often Venous Thromboembolism Occurs in Prostate Cancer Patients in Sweden and NCT03965741 | Bayer | — |
| Completed | Identification of New Genetic Markers for the Risk of Recurrence of Venous Thromboembolism by Whole Genome Ana NCT03977870 | Assistance Publique Hopitaux De Marseille | — |
| Unknown | Evaluation of the Predictive Value of the Microvesicle Coagulo-lytic Balance in the Recurrence of Venous Throm NCT03265054 | Assistance Publique Hopitaux De Marseille | — |
| Completed | Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE) NCT02798471 | Daiichi Sankyo | Phase 3 |
| Completed | A Study of Hospital Healthcare Use and Cost in Patients in the Hospital With a Venous Thromboembolism (VTE) Tr NCT04141228 | Bristol-Myers Squibb | — |
| Completed | A Study to Compare the Risk of a Major Bleeding in Participants Who Received Blood Thinning Medications Follow NCT03521908 | Bristol-Myers Squibb | — |
| Completed | Cancer Venous Thromboembolism (VTE) NCT02073682 | Daiichi Sankyo | Phase 3 |
| Recruiting | VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Ris NCT02156401 | Johannes Gutenberg University Mainz | — |
| Completed | Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study) NCT01583218 | Portola Pharmaceuticals | Phase 3 |
| Completed | EUropean Pharmacogenetics of AntiCoagulant Therapy - Phenprocoumon NCT01119274 | Utrecht Institute for Pharmaceutical Sciences | Phase 4 |